Skip to main content

Marshall Woodworth

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Marshall Woodworth

Marshall Woodworth is recorded as CFO at MetaVia Inc. (MTVA). MetaVia Inc. reported in an 8-K filed March 4, 2024 that Marshall Woodworth was appointed Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, effective March 1, 2024. The proxy statement of MetaVia Inc. reports total compensation of $154,500 for Marshall Woodworth in fiscal 2023. Disclosed compensation is on record for 2 fiscal years.

“NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases of cardiometabolic diseases, today announced the appointment of Marshall Woodworth as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, effective March 1, 2024, following his tenure as Acting Chief Financial Officer since October 27, 2023.”
MetaVia Inc. Form 8-K, filed March 4, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at MetaVia Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 MetaVia Inc. (MTVA) — $154,500
2022 MetaVia Inc. (MTVA) — —

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.